These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32385549)

  • 1. COVID-19, Angiotensin Receptor Blockers, and the Brain.
    Saavedra JM
    Cell Mol Neurobiol; 2020 Jul; 40(5):667-674. PubMed ID: 32385549
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversy regarding ACE inhibitors / ARBs in COVID-19.
    Soria Arcos F; Romero Puche A; Vicente Vera T
    Rev Esp Cardiol (Engl Ed); 2020 Jun; 73(6):516. PubMed ID: 32371022
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Messerli FH; Siontis GCM; Rexhaj E
    Circulation; 2020 Jun; 141(25):2042-2044. PubMed ID: 32282224
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.
    Bavishi C; Maddox TM; Messerli FH
    JAMA Cardiol; 2020 Jul; 5(7):745-747. PubMed ID: 32242890
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.
    Saavedra JM
    Pharmacol Res; 2020 Sep; 159():104958. PubMed ID: 32473311
    [No Abstract]   [Full Text] [Related]  

  • 6. EMA advice on renin-angiotensin system medicines during covid-19 pandemic.
    Drug Ther Bull; 2020 Jun; 58(6):85. PubMed ID: 32295811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
    Eroğlu I; Çelik Eroğlu B; Uyaroğlu OA; Sain Güven G
    Anatol J Cardiol; 2020 Jul; 24(1):19-20. PubMed ID: 32628145
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 10. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 11. The dilemma of renin-angiotensin system inhibitors in coronavirus disease 2019 (COVID-19): insights into lung fluid handling and gas exchange in heart failure patients.
    Guazzi M; Moroni A
    Eur J Heart Fail; 2020 Jun; 22(6):926-928. PubMed ID: 32438449
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
    Shyh GI; Nawarskas JJ; Cheng-Lai A
    Cardiol Rev; 2020; 28(4):213-216. PubMed ID: 32496364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential protective role of losartan against coronavirus-induced lung damage.
    Zeinalian M; Salari-Jazi A; Jannesari A; Khanahmad H
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):752-753. PubMed ID: 32248854
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 15. Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.
    Swayne LA; Johnstone SR; Ng CS; Sanchez-Arias JC; Good ME; Penuela S; Lohman AW; Wolpe AG; Laubach VE; Koval M; Isakson BE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L121-L125. PubMed ID: 32519892
    [No Abstract]   [Full Text] [Related]  

  • 16. Dysregulation of type I interferon responses in COVID-19.
    Acharya D; Liu G; Gack MU
    Nat Rev Immunol; 2020 Jul; 20(7):397-398. PubMed ID: 32457522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
    Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
    Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infects human neural progenitor cells and brain organoids.
    Zhang BZ; Chu H; Han S; Shuai H; Deng J; Hu YF; Gong HR; Lee AC; Zou Z; Yau T; Wu W; Hung IF; Chan JF; Yuen KY; Huang JD
    Cell Res; 2020 Oct; 30(10):928-931. PubMed ID: 32753756
    [No Abstract]   [Full Text] [Related]  

  • 19. The COVID-19 Pandemic and Mayo Clinic Proceedings.
    Nath KA
    Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
    [No Abstract]   [Full Text] [Related]  

  • 20. First motor seizure as presenting symptom of SARS-CoV-2 infection.
    Fasano A; Cavallieri F; Canali E; Valzania F
    Neurol Sci; 2020 Jul; 41(7):1651-1653. PubMed ID: 32417987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.